Fluidigm Co. (NASDAQ:FLDM) insider Levin Capital Strategies, L.P. purchased 100,576 shares of the stock in a transaction that occurred on Wednesday, January 10th. The shares were acquired at an average cost of $6.34 per share, with a total value of $637,651.84. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Levin Capital Strategies, L.P. also recently made the following trade(s):

  • On Wednesday, January 3rd, Levin Capital Strategies, L.P. bought 29 shares of Fluidigm stock. The stock was purchased at an average cost of $6.63 per share, with a total value of $192.27.
  • On Friday, December 28th, Levin Capital Strategies, L.P. bought 30 shares of Fluidigm stock. The stock was purchased at an average cost of $5.82 per share, with a total value of $174.60.
  • On Friday, December 29th, Levin Capital Strategies, L.P. bought 11,230 shares of Fluidigm stock. The stock was purchased at an average cost of $5.94 per share, with a total value of $66,706.20.
  • On Wednesday, December 27th, Levin Capital Strategies, L.P. bought 27,100 shares of Fluidigm stock. The stock was purchased at an average cost of $5.88 per share, with a total value of $159,348.00.
  • On Friday, December 15th, Levin Capital Strategies, L.P. bought 24,175 shares of Fluidigm stock. The stock was purchased at an average cost of $5.84 per share, with a total value of $141,182.00.
  • On Tuesday, December 12th, Levin Capital Strategies, L.P. bought 18,569 shares of Fluidigm stock. The stock was purchased at an average cost of $5.84 per share, with a total value of $108,442.96.
  • On Monday, December 4th, Levin Capital Strategies, L.P. bought 8,409 shares of Fluidigm stock. The stock was purchased at an average cost of $5.48 per share, with a total value of $46,081.32.
  • On Wednesday, November 29th, Levin Capital Strategies, L.P. bought 20,380 shares of Fluidigm stock. The stock was purchased at an average cost of $5.71 per share, with a total value of $116,369.80.
  • On Friday, November 17th, Levin Capital Strategies, L.P. bought 6,880 shares of Fluidigm stock. The stock was purchased at an average cost of $5.05 per share, with a total value of $34,744.00.
  • On Wednesday, November 8th, Levin Capital Strategies, L.P. bought 54,900 shares of Fluidigm stock. The stock was purchased at an average cost of $5.26 per share, with a total value of $288,774.00.

Shares of Fluidigm Co. (FLDM) traded down $0.21 during trading on Thursday, reaching $6.32. 217,639 shares of the company’s stock traded hands, compared to its average volume of 226,991. The company has a debt-to-equity ratio of 5.00, a current ratio of 3.02 and a quick ratio of 2.46. The stock has a market capitalization of $247.73, a PE ratio of -2.83 and a beta of 3.37. Fluidigm Co. has a twelve month low of $2.52 and a twelve month high of $8.04.

Separately, ValuEngine cut shares of Fluidigm from a “sell” rating to a “strong sell” rating in a report on Thursday, November 9th.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Teachers Advisors LLC grew its position in Fluidigm by 1.8% during the second quarter. Teachers Advisors LLC now owns 56,662 shares of the medical research company’s stock valued at $229,000 after buying an additional 999 shares during the period. Alliancebernstein L.P. grew its position in Fluidigm by 18.4% during the second quarter. Alliancebernstein L.P. now owns 45,700 shares of the medical research company’s stock valued at $185,000 after buying an additional 7,100 shares during the period. PDT Partners LLC grew its position in Fluidigm by 56.0% during the second quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after buying an additional 9,800 shares during the period. Bank of New York Mellon Corp grew its position in Fluidigm by 5.5% during the second quarter. Bank of New York Mellon Corp now owns 217,839 shares of the medical research company’s stock valued at $880,000 after buying an additional 11,261 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Fluidigm by 9.3% during the second quarter. Dimensional Fund Advisors LP now owns 136,003 shares of the medical research company’s stock valued at $549,000 after buying an additional 11,557 shares during the period. Institutional investors own 93.27% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This article was first reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://www.americanbankingnews.com/2018/01/11/levin-capital-strategies-l-p-acquires-100576-shares-of-fluidigm-co-fldm-stock.html.

About Fluidigm

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Insider Buying and Selling by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.